Altered emotional behavior in PACAP-type-I-receptor-deficient mice

被引:119
作者
Otto, C
Martin, M
Wolfer, DP
Lipp, HP
Maldonado, R
Schütz, G
机构
[1] German Canc Res Ctr, Div Cell & Mol Biol, D-69120 Heidelberg, Germany
[2] Univ Pompeu Fabra, Dept Neuropharmacol, Barcelona 08003, Spain
[3] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland
来源
MOLECULAR BRAIN RESEARCH | 2001年 / 92卷 / 1-2期
关键词
PACAP; PACAP-type-I-receptor (PAC1); gene targeting; anxiety-like behavior; hyperactivity;
D O I
10.1016/S0169-328X(01)00153-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
PAC1 (pituitary adenylate cyclase activating polypeptide type I receptor) is a G-protein-coupled receptor that binds the strongly conserved neuropeptide PACAP (pituitary adenylate cyclase activating polypeptide) with a thousandfold higher affinity than the related peptide VIP (vasoactive intestinal peptide). PAC1 shows strong expression in brain areas which have been implicated in the emotional control of behavior, such as the amygdala, the hypothalamus, the locus coeruleus and the periaqueductal gray. To assess whether PAC1-mediated signaling has an impact on emotional behavior, we analysed two different mutant mouse lines with an ubiquitous or a forebrain-specific inactivation of PAC1 in several testing paradigms modelling general locomotor activity and anxiety-related behavior. We clearly demonstrate that mice with a ubiquitous but not with a forebrain-specific deletion of PAC I exhibit elevated locomotor activity and strongly reduced anxiety-like behavior. We could not observe any gross alteration in circadian rhythmicity nor any enhanced sensitivity towards ethanol in the mutant mice. We previously demonstrated that PAC I plays a crucial role in contextual fear conditioning. Therefore the finding that PAC1-deficient mice exhibit reduced anxiety is quite exciting, since the receptor and hence, its ligand PACAP seem to be important for both, innate and learned fear. (C) 2001 Elsevier Science BY. All rights reserved.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 24 条
[1]   Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems [J].
Arimura, A .
JAPANESE JOURNAL OF PHYSIOLOGY, 1998, 48 (05) :301-331
[2]   Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning [J].
Balschun, D ;
Wolfer, DP ;
Bertocchini, F ;
Barone, V ;
Conti, A ;
Zuschratter, W ;
Missiaen, L ;
Lipp, HP ;
Frey, JU ;
Sorrentino, V .
EMBO JOURNAL, 1999, 18 (19) :5264-5273
[3]  
Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419
[4]   Pituitary adenylyl cyclase-activating peptide: A pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock [J].
Chen, D ;
Buchanan, GF ;
Ding, JM ;
Hannibal, J ;
Gillette, MU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13468-13473
[5]   TYPE-I RECEPTORS FOR PACAP (A NEUROPEPTIDE EVEN MORE IMPORTANT THAN VIP) [J].
CHRISTOPHE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (02) :183-199
[6]   Genetics of mouse behavior: Interactions with laboratory environment [J].
Crabbe, JC ;
Wahlsten, D ;
Dudek, BC .
SCIENCE, 1999, 284 (5420) :1670-1672
[7]   Cellular and molecular neuroscience of alcoholism [J].
Diamond, I ;
Gordon, AS .
PHYSIOLOGICAL REVIEWS, 1997, 77 (01) :1-20
[8]   COMPARISON BETWEEN THE BEHAVIORAL-EFFECTS OF SEPTAL AND HIPPOCAMPAL-LESIONS - A REVIEW [J].
GRAY, JA ;
MCNAUGHTON, N .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1983, 7 (02) :119-188
[9]   Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: A potential daytime regulator of the biological clock [J].
Hannibal, J ;
Ding, JM ;
Chen, D ;
Fahrenkrug, J ;
Larsen, PJ ;
Gillette, MU ;
Mikkelsen, JD .
JOURNAL OF NEUROSCIENCE, 1997, 17 (07) :2637-2644
[10]  
Harrington ME, 1999, J NEUROSCI, V19, P6637